These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Clinical Course and Risk Factors for Infection in Severe Forms of Alcohol-Associated Liver Disease. Otero Sanchez L; Karakike E; Njimi H; Putignano A; Degré D; Hites M; Jacobs F; Moreno C; Trepo E; Gustot T Hepatology; 2021 Nov; 74(5):2714-2724. PubMed ID: 34046927 [TBL] [Abstract][Full Text] [Related]
4. Infections in severe alcoholic hepatitis. Karakike E; Moreno C; Gustot T Ann Gastroenterol; 2017; 30(2):152-160. PubMed ID: 28243035 [TBL] [Abstract][Full Text] [Related]
5. In Patients With Severe Alcoholic Hepatitis, Prednisolone Increases Susceptibility to Infection and Infection-Related Mortality, and Is Associated With High Circulating Levels of Bacterial DNA. Vergis N; Atkinson SR; Knapp S; Maurice J; Allison M; Austin A; Forrest EH; Masson S; McCune A; Patch D; Richardson P; Gleeson D; Ryder SD; Wright M; Thursz MR Gastroenterology; 2017 Apr; 152(5):1068-1077.e4. PubMed ID: 28043903 [TBL] [Abstract][Full Text] [Related]
6. Application of prognostic scores in the STOPAH trial: Discriminant function is no longer the optimal scoring system in alcoholic hepatitis. Forrest EH; Atkinson SR; Richardson P; Masson S; Ryder S; Thursz MR; Allison M; J Hepatol; 2018 Mar; 68(3):511-518. PubMed ID: 29175535 [TBL] [Abstract][Full Text] [Related]
7. New paradigms in management of alcoholic hepatitis: a review. Sidhu SS; Goyal O; Kishore H; Sidhu S Hepatol Int; 2017 May; 11(3):255-267. PubMed ID: 28247264 [TBL] [Abstract][Full Text] [Related]
8. Corticosteroids and occurrence of and mortality from infections in severe alcoholic hepatitis: a meta-analysis of randomized trials. Hmoud BS; Patel K; Bataller R; Singal AK Liver Int; 2016 May; 36(5):721-8. PubMed ID: 26279269 [TBL] [Abstract][Full Text] [Related]
9. Invasive aspergillosis in patients with severe alcoholic hepatitis. Gustot T; Maillart E; Bocci M; Surin R; Trépo E; Degré D; Lucidi V; Taccone FS; Delforge ML; Vincent JL; Donckier V; Jacobs F; Moreno C J Hepatol; 2014 Feb; 60(2):267-74. PubMed ID: 24055548 [TBL] [Abstract][Full Text] [Related]
10. IL-33/ST2 pathway regulates neutrophil migration and predicts outcome in patients with severe alcoholic hepatitis. Artru F; Bou Saleh M; Maggiotto F; Lassailly G; Ningarhari M; Demaret J; Ntandja-Wandji LC; Pais de Barros JP; Labreuche J; Drumez E; Helou DG; Dharancy S; Gantier E; Périanin A; Chollet-Martin S; Bataller R; Mathurin P; Dubuquoy L; Louvet A J Hepatol; 2020 Jun; 72(6):1052-1061. PubMed ID: 31953139 [TBL] [Abstract][Full Text] [Related]
11. Epigenetic basis for monocyte dysfunction in patients with severe alcoholic hepatitis. Weichselbaum L; Azouz A; Smolen KK; Das J; Splittgerber M; Lepida A; Moreno C; Schreiber J; Sersté T; Trepo E; Libert F; Gustot T; Goriely S J Hepatol; 2020 Aug; 73(2):303-314. PubMed ID: 32145259 [TBL] [Abstract][Full Text] [Related]
12. Day-4 Lille Score Is a Good Prognostic Factor and Early Predictor in Assessing Therapy Response in Patients with Liver Cirrhosis and Severe Alcoholic Hepatitis. Foncea CG; Sporea I; Lupușoru R; Moga TV; Bende F; Șirli R; Popescu A J Clin Med; 2021 May; 10(11):. PubMed ID: 34071799 [TBL] [Abstract][Full Text] [Related]
13. A Day-4 Lille Model Predicts Response to Corticosteroids and Mortality in Severe Alcoholic Hepatitis. Garcia-Saenz-de-Sicilia M; Duvoor C; Altamirano J; Chavez-Araujo R; Prado V; de Lourdes Candolo-Martinelli A; Holanda-Almeida P; Becerra-Martins-de-Oliveira B; Fernandez-de-Almeida S; Bataller R; Caballeria J; Duarte-Rojo A Am J Gastroenterol; 2017 Feb; 112(2):306-315. PubMed ID: 27922027 [TBL] [Abstract][Full Text] [Related]
14. Corticosteroid plus pentoxifylline is not better than corticosteroid alone for improving survival in severe alcoholic hepatitis (COPE trial). Sidhu SS; Goyal O; Singla P; Gupta D; Sood A; Chhina RS; Soni RK Dig Dis Sci; 2012 Jun; 57(6):1664-71. PubMed ID: 22388710 [TBL] [Abstract][Full Text] [Related]
16. SIRS at Admission Is a Predictor of AKI Development and Mortality in Hospitalized Patients with Severe Alcoholic Hepatitis. Maiwall R; Chandel SS; Wani Z; Kumar S; Sarin SK Dig Dis Sci; 2016 Mar; 61(3):920-9. PubMed ID: 26470868 [TBL] [Abstract][Full Text] [Related]
17. Recurrent severe alcoholic hepatitis: clinical characteristics and outcomes. Potts JR; Howard MR; Verma S Eur J Gastroenterol Hepatol; 2013 Jun; 25(6):659-64. PubMed ID: 23628964 [TBL] [Abstract][Full Text] [Related]
18. Molecular Ellipticity of Circulating Albumin-Bilirubin Complex Associates With Mortality in Patients With Severe Alcoholic Hepatitis. Das S; Maras JS; Maiwall R; Shasthry SM; Hussain S; Sharma S; Sukriti S; Singh TP; Sarin SK Clin Gastroenterol Hepatol; 2018 Aug; 16(8):1322-1332.e4. PubMed ID: 29155355 [TBL] [Abstract][Full Text] [Related]
19. Efficacy of Granulocyte Colony-stimulating Factor in the Management of Steroid-Nonresponsive Severe Alcoholic Hepatitis: A Double-Blind Randomized Controlled Trial. Shasthry SM; Sharma MK; Shasthry V; Pande A; Sarin SK Hepatology; 2019 Sep; 70(3):802-811. PubMed ID: 30664267 [TBL] [Abstract][Full Text] [Related]
20. Corticosteroids, nutrition, pentoxifylline, or fecal microbiota transplantation for severe alcoholic hepatitis. Philips CA; Phadke N; Ganesan K; Ranade S; Augustine P Indian J Gastroenterol; 2018 May; 37(3):215-225. PubMed ID: 29931479 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]